SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nick Holford, Clinical pharmacology = disease progression + drug action, British Journal of Clinical Pharmacology, 2015, 79, 1
  2. 2
    Linda P. Oosterveld, John C. Allen, Giselle Reinoso, Soo-Hoon Seah, Kay-Yaw Tay, Wing-Lok Au, Louis C.S. Tan, Prognostic factors for early mortality in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 3, 226

    CrossRef

  3. 3
    Roberto Gomeni, Use of predictive models in CNS diseases, Current Opinion in Pharmacology, 2014, 14, 23

    CrossRef

  4. 4
    Nick Holford, A Time to Event Tutorial for Pharmacometricians, CPT: Pharmacometrics & Systems Pharmacology, 2013, 2, 5
  5. 5
    Nicholas H. G. Holford, Thuy C. Vu, John G. Nutt, Authors' response to Marras and Oakes, ‘piecing together the puzzle of progression and mortality in Parkinson's disease’, British Journal of Clinical Pharmacology, 2013, 75, 5
  6. 6
    Nick Holford, Disease progression and neuroscience, Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40, 3, 369

    CrossRef

  7. 7
    Michael Kleinman, Samuel Frank, Epidemiology and Clinical Diagnosis of Parkinson Disease, PET Clinics, 2013, 8, 4, 447

    CrossRef

  8. 8
    Connie Marras, David Oakes, Piecing together the puzzle of progression and mortality in Parkinson's disease, British Journal of Clinical Pharmacology, 2012, 74, 2
  9. 9
    Thuy C. Vu, John G. Nutt, Nicholas H. G. Holford, Progression of motor and nonmotor features of Parkinson's disease and their response to treatment, British Journal of Clinical Pharmacology, 2012, 74, 2